This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Bone scans reveal that Tai Chi Rouli Ball could be a viable non-pharmacological approach for preventing osteoporosis in perimenopausal women, according to a study published May 14 in the Journal of Clinical Densitometry. A group from the First Affiliated Hospital of Xi'an Jiaotong University in China used dual-energy x-ray absorptiometry (DEXA) scans to show that the traditional Chinese sport increased bone density and bone mineral content in various body parts.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
A multiphase CT-based deep learning (DL) algorithm shows comparable performance as radiologists for identifying benign small renal masses (SRMs), including lesions of 1 cm or less, researchers have found. Based on their results, a team led by Chenchen Dai, MD, of Fudan University in Shanghai, China, believe that their deep-learning model could facilitate active surveillance of small benign renal masses.
The commission sued Welsh Carson in September, claiming the New York investment outfit and US Anesthesia Partners have perpetrated an “anticompetive scheme” to drive up prices.
Several neoadjuvant chemotherapy response characteristics are often left out of breast MRI reports, suggest findings presented May 7 at the American Roentgen Ray Society (ARRS) annual meeting. In a talk delivered at the conference, Sheida Ebrahimi, MD, from the University of California, San Diego presented her team’s study, which showed that little to no reports indicate the timing of chemotherapy, changes in background parenchymal enhancement (BPE), and the type of response in the findings sect
Implementing a “positive leadership program” within Michigan Medicine’s Department of Radiology has led to improvements in workplace climate perception and employee engagement.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
The American Society for Radiation Oncology (ASTRO) applauded the introduction of legislation in Congress on May 15 that could radically change the way Medicare pays for radiation therapy. The bill, named the Radiation Oncology Case Rate (ROCR) Value-Based Payment Program Act, could shift the way Medicare pays for the treatments from fee for service to a more patient-centered approach, ASTRO said.
Ultrasound technology developer Butterfly Network has launched its ultrasound-based iQ+ Bladder scanner in the U.S. Butterfly Network's iQ+ Bladder scanner. Image courtesy of Butterfly Network. The bundled system is designed for nursing and bladder scanning customers and includes an iQ+ Bladder probe, streamlined software, a compact rolling cart, a tablet and power splitter, the company said.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
The field of radiology, with its cutting-edge technologies and intricate procedures, offers a unique opportunity for revenue cycle management (RCM) success. Yet navigating the RCM landscape in radiology presents twists, turns, and unexpected challenges. With evolving payer criteria and complex prior authorizations, radiology professionals need tools and the foresight to thrive in an ever-changing healthcare environment.
Health Canada has issued a medical device license to KA Imaging for its Reveal Mobi Pro x-ray system. Reveal Mobi Pro is a dual-energy mobile x-ray scanner that integrates KA Imaging’s Reveal 35C detector with SpectralDR technology into a complete system. The scanner can simultaneously acquire conventional and dual-energy images with a single exposure at the bedside and may be especially useful for ICU patients, the company said.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
Siemens Healthineers company Varian will distribute medical device company Innova Vascular's Laguna Thrombectomy System for treating venous thromboembolism. The Laguna Thrombectomy System consists of the Malibu Aspiration Catheter System and the Laguna Clot Retriever System, which are designed to optimize clot extraction procedures in challenging cases, Varian said.
milla1cf Wed, 05/15/2024 - 18:57 May 15, 2024 — etherFAX announced the expansion of its partnership with Hyland , a leading global provider of intelligent content solutions, with its new integration with Hyland’s OnBase platform. Through the integration, etherFAX and Hyland are enabling healthcare organizations to securely exchange protected health information (PHI) via the cloud.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
At the European Congress of Radiology’s annual meeting Siemens Healthineers unveiled a virtually helium-free MR Scanner which will require no squelch pipe.
milla1cf Wed, 05/15/2024 - 19:01 May 15, 2024 — Heart disease is the leading cause of mortality in the U.S., accounting for one out of every five deaths. What’s more, it is estimated that more than 45% of the U.S. population will have some form of heart disease by 2035, resulting in total costs exceeding $1 trillion. Heart disease is largely preventable, but many people don’t understand their risk until it is too late.
Combining clinical and CT features, adjunctive use of a classification and regression tree (CART) diagnostic model demonstrated AUCs for detecting clear cell renal cell carcinoma (ccRCC) that were 15 to 22 percent higher than unassisted radiologist assessments.
Image by yanalya on Freepik When you’re deep into the recruiting process, it’s easy to have a bit of tunnel vision. The only metric that seems to matter is filling the open positions you’re currently working on. While that is the primary goal of recruiting, it doesn’t indicate the overall success of your efforts. To truly know if your recruiting strategy is working as it should, you must measure performance against some standard metrics and analytics.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content